In addition, suspensions of TCL cell line EL4 were implanted into immunocompetent C57BL/6 mice via subcutaneous injection to evaluate the effect of the cGAS inhibitor RU.521 on tumor suppression and to exclude immune system interference (Figure 3I). The gene discussed is CGAS; the disease is neoplasm.